Home » Celera and Ipsen Enter Research Collaboration to Develop Pharmacogenomic Tests
Celera and Ipsen Enter Research Collaboration to Develop Pharmacogenomic Tests
Celera, an Applera Corporation business, and Ipsen announced that they have entered into a research collaboration to develop biomarker and pharmacogenomic tests for growth failure patients.
Genetic Engineering & biotechnology News
Upcoming Events
-
07May
-
14May
-
30May